|
|
慢加急性肝衰竭预后相关指标及预测模型研究现状
|
Abstract:
慢加急性肝衰竭是肝功能不全终末状态的一种类型，其死亡率高，目前缺乏理想的治疗手段。早期对患者的预后做出准确的预测，有助于优化医疗资源的配置。本文归纳总结了近年来临床常用的预后标志物及评分模型，旨在指导慢加急肝衰竭患者的治疗及预后推测。
Acute-on-chronic liver failure (ACLF) is a type of terminal hepatic insufficiency with high mortality and lack of ideal treatment. Early accurate prognosis of patients is helpful to optimize the allocation of medical resources. This article summarized the commonly used clinical prognostic markers and scoring models in recent years in order to guide the treatment and prognosis of patients with acute-on-chronic liver failure.
| [1] | Bajaj, J.S., O’Leary, J.G., Lai, J.C., et al. (2022) Acute-on-Chronic Liver Failure Clinical Guidelines. The American Journal of Gastroenterology, 117, 225-252. https://doi.org/10.14309/ajg.0000000000001595 |
| [2] | Wu, T., Li, J., et al. (2018) Development of Diagnostic Criteria and a Prognostic Score for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Gut, 67, 2181-2191. https://doi.org/10.1136/gutjnl-2017-314641 |
| [3] | 李兰娟, 韩涛. 肝衰竭诊治指南(2018年版) [J]. 西南医科大学学报, 2019, 42(2): 99-106. |
| [4] | 张译之, 陈煜. 慢加急性肝衰竭定义、临床特征、治疗与预后的异质性探讨[J]. 肝脏, 2021, 26(10): 1072-1074. |
| [5] | 黄湛镰, 高志良. 肝衰竭的三重打击及治疗策略[J]. 内科急危重症杂志, 2014, 20(3): 154-156. |
| [6] | 陈渊渊, 孟忠吉. 系统性炎症在慢加急性肝衰竭发病机制中的作用[J]. 中西医结合肝病杂志, 2021, 31(10): 951-955. |
| [7] | 梁丽丽, 金苏素, 杜静园, 等. 中性粒细胞淋巴细胞比值联合慢性肝衰竭-器官衰竭评分在预测乙型肝炎慢加急性肝衰竭短期预后的价值研究[J]. 现代实用医学, 2020, 32(4): 450-452+563. |
| [8] | 梁丽丽, 金苏素, 杜静园, 等. 中性粒细胞淋巴细胞比值联合慢性肝衰竭-器官衰竭评分在预测乙型肝炎慢加急性肝衰竭短期预后的价值研究[J]. 现代实用医学, 2020, 32(4): 450-452. |
| [9] | 关菁, 徐玉敏, 等. 外周血中性粒细胞与淋巴细胞数的比值预测慢加急性肝衰竭疾病进展和临床转归的研究[J]. 肝脏, 2019, 24(2): 130-132. |
| [10] | 陈小琴, 林志刚. 血清PCT、CRP、PTA联合MELD评分系统预测ACLF患者短期预后的价值[J]. 医学理论与实践, 2021, 34(23): 4164-4166. |
| [11] | 谭立明, 蒙仪妹, 等. 降钙素原、D-二聚体、C-反应蛋白对慢加急性肝衰竭患者并发感染的临床意义[J]. 实用医学杂志, 2018, 34(3): 410-415. |
| [12] | Gilbert, D.N. (2010) Use of Plasma Procalcitonin Levels as an Adjunct to Clinical Microbiology. Journal of Clinical Microbiology, 48, 2325-2329. https://doi.org/10.1128/JCM.00655-10 |
| [13] | 傅叁君, 高国生, 等. 血清降钙素原和常用炎症指标联合CTP评分对慢加急性肝衰竭短期预后的预测价值[J]. 中国实用内科杂志, 2015, 35(6): 519-521. |
| [14] | Qu, J., Feng, P., et al. (2016) Impact of Hepatic Function on Serum Procalcitonin for the Diagnosis of Bacterial Infections in Patients with Chronic Liver Disease: A Retrospective Analysis of 324 Cases. Medicine, 95, e4270.
https://doi.org/10.1097/MD.0000000000004270 |
| [15] | Stanley, A.C. and Lacy, P. (2010) Pathways for Cytokine Secretion. Physiology (Bethesda, Md), 25, 218-229.
https://doi.org/10.1152/physiol.00017.2010 |
| [16] | 黄春光, 杨洁飞, 等. 分子吸附再循环系统治疗肝衰竭患者细胞因子水平变化的应用研究[J]. 实验与检验医学, 2013, 31(2): 141-142. |
| [17] | 李晨, 王慧芬, 等. HBV相关慢加急性肝衰竭患者体内细胞因子表达及动态变化的研究[J]. 传染病信息, 2011, 24(3): 151-155. |
| [18] | European Associ-ation for the Study of the Liver (2016) EASL Clinical Practice Guidelines: Liver transplantation. Journal of Hepatology, 64, 433-485. https://doi.org/10.1016/j.jhep.2015.10.006 |
| [19] | 王媛慧, 刘源, 等. 应用乳酸脱氢酶建立预测模型评估慢加急性肝衰竭预后[J]. 南京医科大学学报(自然科学版), 2020, 40(7): 996-1001. |
| [20] | Gao, F., Huang, X.L., et al. (2019) Prognostic Value of Serum Lactate Kinetics in Critically Ill Patients with Cirrhosis and Acute-on-Chronic Liver Failure: A Multicenter Study. Aging, 11, 4446-4462.
https://doi.org/10.18632/aging.102062 |
| [21] | 陈丽, 罗二平, 等. 慢加急性肝衰竭患者血清中乳酸脱氢酶的临床意义[J]. 胃肠病学和肝病学杂志, 2010, 19(4): 339-341. |
| [22] | 张国华. 血清前白蛋白、胆碱酯酶和总胆汁酸联合检测在肝病诊断中的价值[J]. 交通医学, 2016, 30(6): 615-616. |
| [23] | 宋少娟, 苏国华. 血清总胆汁酸、胆碱酯酶和前白蛋白检测在肝病诊断中应用探析[J]. 医学信息, 2021, 34(23): 9-11. |
| [24] | 李艳艳, 徐龙. 血清前白蛋白与总胆红素比值、ALBI评分、MELD评分与慢加急性肝衰竭患者预后的关系[J]. 中西医结合肝病杂志, 2020, 30(5): 417-419. |
| [25] | 蒋彬, 吴雯雯, 等. 血脂水平对乙型肝炎病毒相关性肝衰竭预后判断的价值[J]. 浙江临床医学, 2015, 17(5): 815-816. |
| [26] | 章颖, 明芳, 等. 血清甲状腺激素、血脂水平、联合血钠的终末期肝病模型评分对血浆置换治疗慢加急性肝衰竭患者短期预后的评估价值[J]. 上海医学, 2021, 44(4): 237-241. |
| [27] | 汤朝晖, 全志伟, 等. AFP、GPC3、ZHX2及ZBTB20基因在小鼠肝脏再生过程中的表达及其意义[J]. 中华肝脏外科手术学电子杂志, 2013, 2(1): 39-44. |
| [28] | Wang, X., Shen, C., et al. (2018) Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure. Canadian Journal of Gastroenterology and Hepatology, 2018, Article ID: 1232785.
https://doi.org/10.1155/2018/1232785 |
| [29] | 苗静, 吴素琼, 等. 甲胎蛋白和胆碱酯酶在乙型肝炎病毒相关慢加急性肝衰竭患者中应用价值的研究[J]. 中华危重病急救医学, 2016, 28(3): 257-261. |
| [30] | Wang, X., Sun, M., et al. (2020) Value of Liver Regeneration in Predicting Short-Term Prognosis for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure. BioMed Research International, 2020, Article ID: 5062873.
https://doi.org/10.1155/2020/5062873 |
| [31] | Wu, D., Sun, Z., et al. (2018) HINT: A Novel Prognostic Model for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Alimentary Pharmacology & Therapeutics, 48, 750-760. https://doi.org/10.1111/apt.14927 |
| [32] | Durand, F., Francoz, C., et al. (2018) Acute Kidney Injury after Liver Transplantation. Transplantation, 102, 1636-1649.
https://doi.org/10.1097/TP.0000000000002305 |
| [33] | 童晶晶, 穆秀颖, 等. 血氨与HBV相关慢加急性肝衰竭患者90天预后的关系[J]. 临床肝胆病杂志, 2019, 35(6): 1304-1307. |
| [34] | Wang, X., Sarin, S.K., et al. (2015) Defini-tion of ACLF and Inclusion Criteria for Extra-Hepatic Organ Failure. Hepatology International, 9, 360-365. https://doi.org/10.1007/s12072-015-9637-x |
| [35] | Belcher, J.M., Sanyal, A.J., et al. (2014) Kidney Biomarkers and Differential Diagnosis of Patients with Cirrhosis and Acute Kidney Injury. Hepatology, 60, 622-632. https://doi.org/10.1002/hep.26980 |
| [36] | National Kidney Foundation (2015) KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update. American Journal of Kidney Diseases: The Official Journal of the National Kid-ney Foundation, 66, 884-930. |
| [37] | Markwardt, D., Holdt, L., et al. (2017) Plasma Cystatin C Is a Predictor of Renal Dysfunction, Acute-on-Chronic Liver Failure, and Mortality in Patients with Acutely Decompensated Liver Cirrhosis. Hepatology, 66, 1232-1241.
https://doi.org/10.1002/hep.29290 |
| [38] | 徐晓琳. Cys-C、β2-MG、Scr和BUN水平在预测慢加急性肝衰竭患者合并肝肾综合征中的价值[J]. 世界华人消化杂志, 2018, 26(12): 700-706. |
| [39] | 杨凯, 刘治华, 等. 血清尿酸评估HBV相关性慢加急性肝衰竭预后的临床价值[J]. 安徽医专学报, 2021, 20(4): 89. |
| [40] | 张东敬, 周彬, 等. 慢加急性肝衰竭预后模型的研究进展[J]. 临床肝胆病杂志, 2018, 34(6): 1351-1356. |
| [41] | Malinchoc, M., Kamath, P.S., et al. (2000) A Model to Predict Poor Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunts. Hepatology, 31, 864-871. https://doi.org/10.1053/he.2000.5852 |
| [42] | 刘艳梅, 刘先进, 等. 不同评分系统判断乙型肝炎慢加急性肝衰竭预后的价值[J]. 中华传染病杂志, 2015, 33(12): 737-741. |
| [43] | Zheng, Y.X., Zhong, X., et al. (2017) Performance of Scoring Systems to Predict Mortality of Patients with Acute-on-Chronic Liver Failure: A System-atic Review and Meta-Analysis. Journal of Gastroenterology and Hepatology, 32, 1668-1678. https://doi.org/10.1111/jgh.13786 |
| [44] | 李晨, 游绍莉, 等. 基线MELD、MELD-Na、iMELD 3种模型对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值[J]. 中华危重病急救医学, 2014, 26(8): 539-543. |
| [45] | Rumyantseva, T., et al. (2018) Bacterial Infection-Triggered Acute-on-Chronic Liver Failure Is Associat-ed with Increased Mortality. Liver International: Official Journal of the International Association for the Study of the Liver, 38, 645-653. https://doi.org/10.1111/liv.13568 |
| [46] | 田小利, 吴松林, 等. COSSH-ACLFs评分模型对HBV相关慢加急性肝衰竭患者短期预后的预测价值[J]. 临床肝胆病杂志, 2020, 36(6): 1258-1262. |
| [47] | Choudhury, A., Jindal, A., et al. (2017) Liver Failure Determines the Outcome in Patients of Acute-on-Chronic Liver Failure (ACLF): Comparison of APASL ACLF Research Consortium (AARC) and CLIF-SOFA Models. Hepatology International, 11, 461-471. https://doi.org/10.1007/s12072-017-9816-z |
| [48] | 张文佳, 赵丽娟, 等. MELD、AARC、COSSH评分系统对乙型肝炎相关慢加急性肝衰竭90天预后的评估价值[J]. 临床肝胆病杂志, 2020, 36(4): 813-817. |
